| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.096 | 0.02 |